Related Experiment Video
Updated: May 27, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
The inherited disorders of haemoglobin: an increasingly neglected global health burden
1Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom. liz.rose@imm.ox.ac.uk
Insights
Severe inherited hemoglobin diseases affect 300,000 newborns annually, primarily in low-income nations. Improved healthcare increases survival, highlighting the urgent need for global data and collaborative action.
Area of Science:
- Medical Genetics
- Global Public Health
- Hematology
Background:
- Severe inherited hemoglobin diseases affect approximately 300,000 newborns globally each year.
- Over 80% of these births occur in low- and middle-income countries.
- Epidemiological transitions in these nations lead to increased survival of infants with these conditions.
Purpose of the Study:
- To highlight the critical need for accurate global data on the frequency, natural history, and survival of inherited hemoglobin diseases.
- To underscore the growing global health burden of these conditions.
- To advocate for international collaboration and resource allocation.
Main Methods:
- This study is based on an analysis of existing global health statistics and epidemiological trends.
- It synthesizes information on the prevalence and impact of inherited hemoglobin disorders.
- The approach involves identifying data gaps and proposing solutions for improved health outcomes.
Main Results:
- Accurate data on the true frequency, natural history, and survival rates of patients with inherited hemoglobin disorders are limited, even in high-income countries.
- The survival of affected infants is increasing in low- and middle-income countries due to public health improvements.
- This increasing survival presents diagnostic and treatment challenges in resource-limited settings.
Conclusions:
- Major action from high-income countries is essential to address the global health burden of inherited hemoglobin diseases.
- Partnerships between high-income and low-income countries, supported by international health agencies, are crucial.
- Improved data collection and international cooperation are vital for effective management and treatment strategies.
Abstract:
An estimated 300,000 babies are born each year with a severe inherited disease of haemoglobin and that over 80 per cent of these births occur in low- or middle-income countries. As these countries go through the epidemiological transition, characterized by a reduction in childhood and infant mortality due to improved public health measures, infants who had previously died of these conditions before they were recognised are now surviving to present for diagnosis and treatment. For a variety of reasons, even in the rich countries there are limited data about the true frequency, natural history, and survival of patients with these disorders, information that is absolutely critical towards providing governments and international health agencies with accurate information about the true global health burden of these conditions. The situation can only be improved by major action on the part of the rich countries together with the formation of partnerships between rich and poor countries and input from the major international health agencies and funding organisations.
Related Concept Videos
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:49Multiple Allele Traits
01:43Sex-linked Disorders